SCHEMBL20261069

SCHEMBL20261069

CCCCCCCCN(CCOCCO)C(C)=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
THRB P10828 1/20 0.52
HTT P42858 1/20 0.52
MAPT P10636 1/20 0.52
TSHR P16473 3/20 0.47
ZDHHC20 Q5W0Z9 2/20 0.43
CES2 O00748 1/20 0.41
USP2 O75604 1/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAPK1 P28482 1/20 0.40
CASP1 P29466 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
SLCO1B3 Q9NPD5 1/20 0.40
SLCO1B1 Q9Y6L6 1/20 0.40
CA12 O43570 2/20 0.38
CA1 P00915 2/20 0.38
CA9 Q16790 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20261073 0.87 MEN1 (0.47) MEN1KMT2ATHRBHTTMAPT
SCHEMBL22813895 0.84 ZDHHC20 (0.49) MEN1KMT2ATHRBHTTMAPT
SCHEMBL8115453 0.84 MEN1 (0.49) MEN1KMT2ATHRBHTTMAPT
SCHEMBL8101448 0.84 MEN1 (0.49) MEN1KMT2ATHRBHTTMAPT
SCHEMBL26801512 0.84 MEN1 (0.49) MEN1KMT2ATHRBHTTMAPT
SCHEMBL8108773 0.84 MEN1 (0.49) MEN1KMT2ATHRBHTTMAPT
Ethylene Glycol SCHEMBL7253062 0.84 CA12 (0.47) MEN1KMT2ATSHRZDHHC20CES2
SCHEMBL24288771 0.83 MEN1 (0.47) MEN1KMT2ATHRBHTTMAPT
SCHEMBL20261072 0.82 LMNA (0.48) MEN1KMT2ATSHRZDHHC20CES2
SCHEMBL22986005 0.82 CA12 (0.45) MEN1KMT2ATHRBTSHRZDHHC20

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023114937-A2 FLUORINATED CATIONIC LIPIDS FOR USE IN LIPID NANOPARTICLES Acuitas Therapeutics, Inc. (CA) 2023-06-22 WO disclosed
WO-2021030701-A1 IMPROVED LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS Acuitas Therapeutics, Inc. (CA) 2021-02-18 WO disclosed
WO-2018107026-A1 DELIVERY OF TARGET SPECIFIC NUCLEASES SANGAMO THERAPEUTICS, INC. (US) 2018-06-14 WO disclosed